Astera Labs (ALAB) Could Be 59% Undervalued After Orion Launch And ETF Buying

Astera Labs (ALAB) is in focus after unveiling Orion, a modular rack-scale reference design aimed at compute-agnostic AI infrastructure, along with fresh ETF inflows that highlight growing institutional interest in the stock.

Recent trading tells a mixed story. The share price has pulled back sharply, with the 7-day share price return down 10.03% and the 30-day share price return down 29.47%, even though the year-to-date share price return sits at 43.22% and the 1-year total shareholder return is 55.88%. This indicates that Astera Labs has shown relatively strong longer-term performance despite short-term profit taking and shifting views on AI infrastructure risk.

Seize this moment in AI infrastructure by lining up Astera Labs with a curated group of 55 AI infrastructure stocks that are also drawing fresh institutional attention.

Astera Labs is building real products like Orion and generating real revenue, yet the share price has recently declined from its highs. Is this still a strong AI infrastructure business trading at a stretched price, or a reset worth studying more closely on valuation grounds?

Most Popular Narrative: 59% Undervalued

On the numbers alone, the narrative fair value of $628.83 sits well above Astera Labs' last close at $257.16, so the current pullback is being weighed against a framework that already includes ambitious growth, margins, and risk.

The thesis is that rack-scale connectivity is a genuine bottleneck, that content per accelerator is rising faster than accelerator units, and that a software layer embedded in hyperscaler fleet management is a real moat even without a fab. Everything in the June quarter supported that.

See why 53 investors see Astera Labs as 59% undervalued.

Result: Fair Value of $628.83 (UNDERVALUED)

Still, the whole Astera Labs story leans heavily on one hyperscaler and very high valuation expectations, so any customer shift or multiple reset could hit the thesis hard.

Find out about the key risks to this Astera Labs narrative.

Another View on Astera Labs Valuation

The fair value narrative presents Astera Labs as materially undervalued, yet the market is charging a steep entry price. The current P/E of 120.7x is almost triple the US Semiconductor sector at 42.6x and roughly double the peer average of 61x, while the fair ratio is 54.8x. That gap suggests investors are already paying forward a lot of success, so it is important to consider how comfortable you are with that level of valuation risk.

To pressure test that premium further and assess what the numbers imply if the market moves back toward the fair ratio, it is useful to review the valuation breakdown in detail, including how earnings quality and forecast growth compare with that multiple profile. See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Sentiment around Astera Labs is split, with strong long-term returns and sharp recent volatility. Act quickly by checking both sides of the story through 3 key rewards and 3 important warning signs.

Looking for more investment ideas beyond Astera Labs?

If Astera Labs has your attention, do not stop here. Broaden your watchlist with fresh opportunities that tap different parts of the market.

• Target steadier compounding potential by reviewing a curated group of 29 high quality undervalued stocks that pair solid fundamentals with what our models flag as discounted prices.
• Secure your income stream by assessing a focused selection of 5 dividend fortresses designed for investors who want yield backed by financial strength.
• Protect your downside by scanning a basket of 30 resilient stocks with low risk scores that score well on resilience and balance sheet quality.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com